Case report: Severe acute hepatitis in a 22-month-old Chinese boy with Omicron sub-variant BA.2.38

The etiology of severe acute hepatitis (SAH) in children is various. We describe the first Chinese case of severe acute hepatitis in a 22-month-old boy with the mild illness of Omicron sub-variant BA.2.38. With the application of Compound Glycyrrhizin Injection (CGI), the patient gradually recovered...

Full description

Bibliographic Details
Published in:	Frontiers in Public Health
Main Authors:	Xinying Chen, Junbin Hong, Yuxia Li, Caixia An, Jianwen Guo, Jinghua Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Subjects:	severe acute hepatitis SARS-CoV-2 Omicron variant case report pediatrics
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2022.1012638/full

Similar Items

Clinical and humoral immune response characterization of SARS-CoV-2 Omicron BA.2.38 infection in pediatric patients
by: Yu Liu, et al.
Published: (2023-07-01)

Association between levels of IgG antibodies from vaccines and Omicron symptomatic infection among children and adolescents in China
by: Xinying Chen, et al.
Published: (2023-08-01)

Outcome of Transplant Recipients Infected with Omicron BA.1 and BA.2: A Single-Center Retrospective Study in Saudi Arabia
by: Abeer N. Alshukairi, et al.
Published: (2023-01-01)

First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco
by: Philippe Colson, et al.
Published: (2022-09-01)

Epidemiological characteristics of a local COVID-19 outbreak caused by Omicron (BA.2.2) variant in Henan province
by: Jing-jing PAN, et al.
Published: (2022-08-01)

Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
by: Sachiko Kodera, et al.
Published: (2022-10-01)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
by: Maarten E. Emmelot, et al.
Published: (2022-12-01)

The Difference in Wave Dynamics between SARS-CoV-2 Pre-Omicron and Omicron Variant Waves
by: Franz Konstantin Fuss, et al.
Published: (2022-12-01)

Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
by: Hope R. Lapointe, et al.
Published: (2022-09-01)

Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant
by: Meriem Bekliz, et al.
Published: (2022-08-01)

Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
by: Carolina Torres, et al.
Published: (2023-01-01)

Iota-Carrageenan Inhibits Replication of the SARS-CoV-2 Variants of Concern Omicron BA.1, BA.2 and BA.5
by: Christian Setz, et al.
Published: (2023-07-01)

The Environmental Stability of SARS-CoV-2 Variants Omicron BA.1 and BA.5 on the Surfaces of Widely Used Transport Packaging Materials
by: Bei Wang, et al.
Published: (2023-06-01)

Association Between mRNA Vaccination and Infection From SARS-CoV-2 During the Delta and Omicron BA.1 Waves: A Population-Level Analysis
by: Allison P. Plaxco, MPH, et al.
Published: (2023-12-01)

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic
by: Dani Cohen, et al.
Published: (2023-07-01)

Immunogenicity and Breakthrough Outcomes of mRNA Booster Strategies Among Healthcare Workers During the BA.1/BA.2 Omicron Surge
by: Song Mi Moon, et al.
Published: (2025-10-01)

Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts
by: Ting Zeng, et al.
Published: (2023-10-01)

Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave
by: Ali Raza Bukhari, et al.
Published: (2023-08-01)

Viral load of SARS‐CoV‐2 Omicron BA.5 is lower than that of BA.2 despite the higher infectivity of BA.5
by: Yuna Takatsuki, et al.
Published: (2023-02-01)

Real world effectiveness of sotrovimab in preventing COVID-19–related hospitalisation or death in patients infected with Omicron BA.2
by: Alwaleed Behzad, et al.
Published: (2024-02-01)

Omicron-BA.1 Dispersion Rates in Mexico Varied According to the Regional Epidemic Patterns and the Diversity of Local Delta Subvariants
by: Selene Zárate, et al.
Published: (2023-01-01)

Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections
by: Naoyuki Miyashita, et al.
Published: (2023-05-01)

Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study
by: Hang Shang, et al.
Published: (2024-01-01)

SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant
by: Célia Sentis, et al.
Published: (2022-04-01)

The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
by: Yuntao Zou, et al.
Published: (2022-07-01)

Age-specific transmission dynamics under suppression control measures during SARS-CoV-2 Omicron BA.2 epidemic
by: Wenlong Zhu, et al.
Published: (2023-04-01)

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
by: Ka-Wa Khong, et al.
Published: (2022-01-01)

Clinical manifestations of SARS-CoV-2 Omicron infection is associated with the stage of liver cirrhosis
by: Fengjiao Wang, et al.
Published: (2025-04-01)

Simple Wastewater Preparation Protocol Applied to Monitor the Emergence of the Omicron 21L/BA.2 Variant by Genome Sequencing
by: Nathalie Wurtz, et al.
Published: (2023-01-01)

The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
by: Alief Moulana, et al.
Published: (2023-02-01)

Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant
by: Wentai Ma, et al.
Published: (2022-02-01)

Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
by: Alina Seidel, et al.
Published: (2023-03-01)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
by: Shohei Yamamoto, et al.
Published: (2023-05-01)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
by: Nicholas E. Ingraham, et al.
Published: (2021-12-01)

Microwave ablation for high-risk pulmonary nodules in patients infected with the Omicron variant of Sars-Cov-2 within 3 months: a retrospective analysis of safety and efficacy
by: Yuxian Chen, et al.
Published: (2024-10-01)

Deciphering the omicron variant: integrated omics analysis reveals critical biomarkers and pathophysiological pathways
by: Qianyue Yang, et al.
Published: (2024-02-01)

SARS‐CoV‐2 Omicron (BA.4, BA.5) variant: Lessons learned from a new variant during the COVID‐19 pandemic
by: Gisou Erabi, et al.
Published: (2024-02-01)

Laryngo pharyngeal affection of COVID-19 during Delta and Omicron variant (Comparative Study)
by: Hanan Anwar, et al.
Published: (2024-08-01)

Characteristics of Omicron variant-induced SARS-CoV-2 reinfections in Chengdu, China
by: Yingxue DAI, et al.
Published: (2023-04-01)

Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023
by: Jianpeng Cai, et al.
Published: (2024-12-01)